Journal Articles

Donald and Barbara Zucker School of Medicine
Academic Works

2014

Expression of Blimp-1 in dendritic cells modulates
the innate inflammatory response in dextran
sodium sulfate-induced colitis
S. J. Kim
Hofstra Northwell School of Medicine

J. Goldstein
Northwell Health

K. Dorso
Northwell Health

M. Merad
Northwell Health

L. Mayer
Northwell Health
See next page for additional authors

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Pathology Commons
Recommended Citation
Kim S, Goldstein J, Dorso K, Merad M, Mayer L, Crawford J, Gregersen P, Diamond B. Expression of Blimp-1 in dendritic cells
modulates the innate inflammatory response in dextran sodium sulfate-induced colitis. . 2014 Jan 01; 20():Article 682 [ p.]. Available
from: https://academicworks.medicine.hofstra.edu/articles/682. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more
information, please contact academicworks@hofstra.edu.

Authors

S. J. Kim, J. Goldstein, K. Dorso, M. Merad, L. Mayer, J. M. Crawford, P. K. Gregersen, and B. Diamond

This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/682

Expression of Blimp-1 in Dendritic Cells Modulates the Innate
Inflammatory Response in Dextran Sodium Sulfate–Induced
Colitis
Sun Jung Kim,1,2 Jordan Goldstein,1 Kimberly Dorso,1 Miriam Merad,3 Lloyd Mayer,4† James M Crawford,5
Peter K Gregersen,2,6 and Betty Diamond1,2
1

The Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, Manhasset, New York,
United States of America; 2Department of Molecular Medicine, School of Medicine, Hofstra University, Hempstead, New York,
United States of America; 3The Human Immunology Center, Icahn School of Medicine at Mount Sinai, New York, New York, United
States of America; 4The Immunology Institute, Icahn School of Medicine at Mount Sinai (deceased), New York, New York, United
States of America; 5Department of Pathology and Laboratory Medicine, Hofstra North Shore–LIJ School of Medicine, Hempstead,
New York, United States of America; and 6Center for Genomics and Human Genetics, The Feinstein Institute for Medical Research,
Manhasset, New York, United States of America

A single nucleotide polymorphism of PRDM1, the gene encoding Blimp-1, is strongly associated with inflammatory bowel disease. Here, we demonstrate that Blimp-1 in CD103+ dendritic cells (DCs) critically contributes to the regulation of macrophage
homeostasis in the colon. Dextran sodium sulfate (DSS)-exposed Blimp-1cko mice with a deletion of Blimp-1 in CD103+ DCs and
CD11chi macrophages exhibited severe inflammatory symptoms, pronounced weight loss, high mortality, robust infiltration of
neutrophils in epithelial regions of the colon, an increased expression of proinflammatory cytokines and a significant decrease
in CD103+ DCs in the colon compared with DSS exposed wild-type (WT) mice. Purified colonic macrophages from Blimp-1cko
mice expressed increased levels of matrix metalloproteinase 8, 9 and 12 mRNA. WT macrophages cocultured with colonic DCs
but not bone marrow–derived DCs from Blimp-1cko produced increased matrix metalloproteinases in an interleukin (IL)-1β– and
IL-6–dependent manner. Treatment of Blimp-1cko mice with anti–IL-1β and anti–IL-6 abrogated the exaggerated clinical response. Overall, these data demonstrate that Blimp-1 expression in DCs can alter an innate inflammatory response by modulating the activation of myeloid cells. This is a novel mechanism of contribution of Blimp-1 for the pathogenesis of inflammatory
bowel diseases, implicating another therapeutic target for the development of inflammatory bowel disease.
Online address: http://www.molmed.org
doi: 10.2119/molmed.2014.00231

INTRODUCTION
Inflammatory bowel disease (IBD) has a
complex pathogenesis dependent on several factors, including genetic susceptibility of the host, commensal bacteria and
the host immune system (1). Genomewide association studies (GWASs) have
significantly advanced our understanding
of the genetic contribution to IBD, and

†

metaanalyses of GWASs have established
>150 susceptibility loci (2–4). These studies confirmed pathways already identified
and also discovered previously unappreciated pathways, raising novel hypotheses
about disease pathogenesis (5). However,
for most GWAS loci, functional alterations
underlying disease susceptibility remain
unidentified.
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The importance of intestinal microbial
flora in disease development in experimental models is being increasingly appreciated. Microbiome-dependent disease
development was noted in studies of rodents raised in germ-free conditions or
various specific pathogen-free conditions
(6,7). Furthermore, different microbiomes
can lead to different disease pathogenesis
in mouse models of IBD, emphasizing the
key role of commensal bacteria in IBD
pathogenesis (8). The gut microbiome affects homeostasis or activation of immune cells in the intestine through engagement of pattern recognition
receptors, and abnormal expression or activation of pattern recognition receptors
can lead to an inflammatory response in
the intestine (9–12). Pattern recognition
receptor activation by pathogenic gut mi-
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crobes often leads to the expression of
proinflammatory cytokines, which drive
intestinal inflammation (13,14).
Tissue-resident dendritic cells (DCs)
and macrophages are key players in controlling intestinal immune responses (15).
The complexity of intestinal macrophage
and DC subsets is increasingly appreciated; however, the contribution of these
populations to intestinal inflammatory
conditions is still unclear (16). In addition
to the traditional DC markers CD11c and
CD103, DCs can be further subdivided
into Batf3-dependent CD11blo DCs and
Batf3-independent CD11b+ DCs (17). Recently, an additional population of Batf3independent CD11c+CD11b+ DCs that lack
CD103 and CD64 but express chemokine
(C-X3-C motif) receptor 1 (CX3CR1) has
also been described (18,19). CD103CX3CR1int DCs are reported to have an
immunogenic phenotype (20,21) and to
induce the differentiation of TH17 cells
(18). Tissue-resident nonmigratory macrophages include a CD11clo and a CD11c+
population, both of which express high
levels of F4/80, CD64 and the CX3CR1
chemokine receptor. In the steady state,
intestinal DCs and macrophages have been
shown to contribute to gut homeostasis
through production of interleukin (IL)-10
and induction of regulatory T cells (22,23).
DCs showed the strongest alterations
in gene expression among other immune
cells, suggesting a role of genetic alterations in IBD (4). PRDM1, the gene encoding B lymphocyte–induced maturation protein-1 (Blimp-1), has been
demonstrated in GWASs to have IBD susceptibility single nucleotide polymorphisms (SNPs). Moreover, a recent exome
sequencing study identified PRDM1 rare
variants that are associated with IBD (24).
In this study, we investigated a pathologic function of Blimp-1 in DCs by
using a CD11c-driven Blimp-1 knockout
(Blimp-1cko). Blimp-1cko mice exhibited an
exacerbated phenotype with a high mortality after dextran sodium sulfate (DSS)induced colitis. After DSS exposure,
colonic Blimp-1ko DCs exhibited an increased production of IL-1β and IL-6,
and colonic macrophages exhibited a

higher expression of matrix metalloproteinases (MMPs). Increased expression of
IL-1β and IL-6 by Blimp-1ko DCs was responsible for the MMP induction in macrophages. Blockade of both IL-1β and
IL-6 during DSS exposure mitigated the
exacerbated IBD phenotype and mortality in Blimp-1cko mice. Finally, blockade
of MMP by an MMP inhibitor reduced
colitis development, supporting the hypothesis that increased expression of
MMP is responsible for the exacerbated
colitis in DCBlimp-1ko mice.
MATERIAL AND METHODS
Human Samples Preparation and In
Vitro Differentiation of MonocyteDerived DCs
Healthy PRDM1 IBD SNP rs6911490 risk
allele carriers and nonrisk allele–carrying
controls were identified from the genotype and phenotype (GaP) registry at
The Feinstein Institute for Medical Research (Manhasset, NY, USA). Fresh
blood was collected and total peripheral
blood mononuclear cells were purified
by gradient centrifugation with FicollPaque (GE Healthcare Bio-Sciences, Piscataway, NJ, USA) at 260g for 20 min
without break. Peripheral blood
mononuclear cells were collected from
the middle layer and washed with
Hanks balanced salt solution for three
times. CD14+ monocytes were purified
with an EasySep Kit (Stem Cell Technologies, Vancouver, Canada), and the purity
of CD14+ cells was confirmed by flow cytometry. Purified monocytes were cultured in RPMI medium with 10% fetal
bovine serum, penicillin-streptomycin,
6
L-glutamine, 10 U/mL granulocytemacrophage colony-stimulating factor
(GM-CSF) (Peprotech, Rocky Hill, NJ,
USA) and 200 U/mL IL-4 (Peprotech) for
7 d to obtain monocyte-derived DCs
(Mo-DCs). These studies were performed
according to an institutional review
board (IRB)-approved protocol.
Mice and Cell Lines
Blimp-1cko mice on a BALB/C background for over 10 generations were
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bred in The Feinstein Institute for Medical Research animal facility and wildtype (WT) BALB/c mice were purchased
from The Jackson Laboratory (Bar Harbor, ME, USA). To generate CX3CR1-GFP
on Blimp-1cko background, Blimp-1cko
mice were bred with CX3CR1-GFP (The
Jackson Laboratory). All mice strains
were maintained in a specific pathogenfree facility at The Feinstein Institute for
Medical Research.
Ethics
All the experiments conducted in this
study followed the guidelines in the
Guide for the Care and Use of Laboratory Animals by the National Institutes of Health
(25). The protocol was approved by the
committee on the Ethics of Animal Welfare of The Feinstein Institute for Medical
Research (protocol number 2009-048). For
the survival study, we monitored mice
twice a day throughout the experiments
to measure weight and monitor development of sickness. We euthanized mice
when the weight loss reached >25% of
the original weight by CO2. Detailed experimental design and protocol can be
found in Supplementary Data.
DSS-Induced Colitis and Preparation
of Intestinal Cell Suspensions
The 7- to 10-wk-old mice were administered 4% DSS (36,000–50,000 molecular
weight; MP Biomedical LLC, Solon, OH,
USA) in drinking water for 7 consecutive
days. After 7 d, DSS water was replaced
with fresh water to allow the mice to recover. To measure colitis, mice were
weighed and stool was collected every
other day; the stool and rectum of the
mice were also examined for blood. For
inhibition assays, anti–IL-1β and IL-6
(100 μg each) together or separately
(eBioscience, San Diego, CA, USA),
anti–tumor necrosis factor (TNF)α (100 μg)
(eBioscience), doxycycline (50 μg) (SigmaAldrich, St. Louis, MO, USA) or control
IgG (100 μg) were administered by intraperitoneal injection on d 0, 3 and 5 of
DSS treatment. To calculate disease activity index (DAI), colitogenic phenotype
was investigated and scored: weight loss

RESEARCH ARTICLE

(0: 0% loss, 1: 1–5% loss, 2: 5–10% loss,
3: 10–20% loss, and 4: >20% loss from
baseline); stool consistency (0: normal,
2: pasty/semiformed stool that did not
adhere to the anus, and 4: liquid); and
bleeding (0: negative hemoccult test,
2: positive hemoccult test, and 4: gross
bleeding); DAI = scores of (weight loss +
stool consistency + bleeding)/3.
On d 3 or 7 of DSS treatment, mice
were sacrificed and their mesenteric
lymph nodes (mLNs), small intestines
and colons were removed. Colon length
and weight was measured. Peyer patches
were removed from the intestine. Intestines were cut open longitudinally along
their entire length, cleaned and washed
by vortexing three times with complete
medium (2% fetal bovine serum in Hanks
balanced salt solution), and incubated in
complete medium containing 1 mmol/L
DL-dithiothreitol solution (SigmaAldrich) for 20 min while shaking at 37°C
and then incubated in 5 mmol/L ethylenediaminetetraacetic acid (SigmaAldrich) in complete medium for 50 min
while shaking at 37°C. Afterward, the intestines were washed once with complete
medium and incubated in 0.3 mg/mL
collagenase (C5138; Sigma-Aldrich) in
complete medium for 45 min at 37°C.
Antibodies and Flow Cytometry
Analysis of Colon Myeloid Subsets
Anti-mouse F4/80-FITC, CD103-PE,
CD11b-PE-Cy7, CD11c-APC, CD45-APCCy7, MHCII-PB, GR-1-PE-Cy5 and
Siglec-H-efluor450 were all purchased
from eBioscience. Anti-mouse CD4-FITC
was purchased from BD Biosciences (San
Jose, CA, USA).
The colonic, small intestine and mLN
cells were stained and analyzed by flow
cytometry (LSRII; BD Biosciences) or
sorted on a cell sorter (FACSAria; BD
Biosciences) to look at different populations of myeloid cells as well as isolate
cells for RNA extraction and quantitative
polymerase chain reaction (qPCR).
TH17 Cell Differentiation
A 48-well plate was coated with 5 μg/mL
anti-CD3ε antibody (145-2C11). The next

day, total CD4+ T cells (CD45+TCRβ+CD4+)
were purified from colon and incubated
under TH17 differentiation conditions;
2 μg/mL anti-CD28 (37.51), 10 μg/mL
anti-CD4, 10 μg/mL anti–IL-2, 10 μg/mL
anti–interferon (IFN)-γ, 5 ng/mL transforming growth factor (TGF)-β and
20 ng/mL IL-6. All the antibodies were
purchased from BD Biosciences and recombinant cytokines were purchased
from Peprotech. On d 4, cells were restimulated with 100 ng/mL phorbol
myristate acetate, 1 μg/mL ionomycin
and 20 μg/mL brefeldin A for 6 h.
Coculture Assays
DCs were prepared either from bone
marrow–derived DCs (BM-DCs) differentiated with Flt3L (Peprotech) or purified colonic DCs and stimulated with
lipopolysaccharide (LPS) (100 ng/mL) or
muramyl dipeptide (MDP) (100 ng/mL)
for 24 h. After stimulation, DCs were
washed thoroughly and cocultured with
macrophages at a 1:5 (DC:macrophage)
ratio for 3 d. After coculture, macrophages were purified by using F4/80
staining. A total of 10 μg/mL anti–IL-1β
and anti–IL-6 or control IgG were used
for the cytokine-blocking experiments.
Gene Expression Analysis
Total RNA was extracted by an RNeasy
kit (Qiagen, Valencia, CA, USA), and total
RNA was quantified by a Nanodrop™
spectrophotometer (Thermo Scientific
[Thermo Fisher Scientific Inc., Waltham,
MA, USA]). cDNA was synthesized with
iScript™ (Bio-Rad, Hercules, CA, USA).
Amplification was performed with a
LightCycler 480 (Roche, Indianapolis, IN,
USA). Gene-specific primers were purchased from TaqMan gene expression
assay (Invitrogen [Thermo Fisher Scientific]), and relative expression of each
gene was quantified by using HPRT or
Polr2a for normalization.
Cytokine Measurements
Cytokines secreted from either human
Mo-DCs or mouse colonic DCs were measured by multiplex panel designed and
purchased from Meso Scale Discovery

(MSD, Rockville, MD, USA) or by enzymelinked assay (ELISA) (BD Biosciences).
Western Blotting
To measure secreted MMP protein,
colon macrophages were purified by cell
sorter and 2 × 105 cells were cultured in
total 200 μL DC-conditioned medium for
72 h. Supernatant was collected and macrophage cell lysate was prepared in
40 μL RIPA buffer with complete protease inhibitor (Roche). Antibodies for
MMP-12 (ab25897) and MMP-8 (ab81286)
(Abcam, Cambridge, MA, USA) was diluted in 0.5% milk in Tris-buffered saline
with 0.05% Tween 20 (TBST) and applied
to the membrane for overnight rocking at
4°C. The next day, the membrane was
washed with TBST three times, and
horseradish peroxidase–conjugated goat
anti-rabbit antibody was applied. Chemiluminescent light was exposed to X-ray
film and developed.
Statistical Analysis
One-way analysis of variance was applied to determine statistics, and p values
<0.05 were considered significant.
All supplementary materials are available
online at www.molmed.org.
RESULTS
Low Blimp-1 Expression and
Increased Proinflammatory Cytokine
Expression in Mo-DCs from PRDM1 IBD
SNP Carriers
PRDM1 has been identified as a gene
contributing to colitis pathogenesis by
GWASs (3,24). To understand the function of the SNP associated with Blimp-1
in DCs, Mo-DCs were generated from
the SNP rs6911490 risk allele (TT) carriers and nonrisk allele (CC) controls. All
individuals had no evidence of autoimmune disease and therefore gene expression in Mo-DCs was not altered by disease or by immunosuppressive therapy.
Blimp-1 expression was significantly
lower in Mo-DCs from risk allele carriers
compared with control individuals (Figure 1A). When Mo-DCs were stimulated
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Figure 1. Mo-DCs derived from PRDM1 IBD risk allele carrier have low levels of Blimp-1 and increased proinflammatory cytokine expression. (A) Blimp-1 expression was measured by qPCR of Mo-DCs differentiated from monocytes carrying CC nonrisk (control) or TT risk (carrier) of rs6911490. Each dot represents an individual person and the bar represents the mean (n = 7). (B) Mo-DCs differentiated from either control or carrier monocytes as indicated in (A) were incubated with or without 1 μg/mL LPS for 18 h. After stimulation, supernatant
was harvested and the levels of cytokines were measured with a human 9-flex multiplex cytokine kit from MSD. Each dot represents an individual person and the bar represents the mean (n = 7).

with LPS, production of the proinflammatory cytokines IL-6, IL-12 and TNFα
was higher in PRDM1 IBD carrier than in
controls (Figure 1B). We did not identify
significant differences in induction of
other cytokines, such as IL-10, IFNγ,
IL-1β and IL-8 (data not shown).
Increased Susceptibility of Blimp-1cko
Mice to DSS-Induced Acute Colitis
The development of SLE-like phenotypes of Blimp-1cko mice on a C57BL/6
background, obtained by mating CD11ccre mice to floxed Blimp-1 mice, has been
described previously (26). Because
PRDM1 IBD risk allele carriers exhibit a
low level of Blimp-1 and a proinflammatory phenotype in Mo-DCs, we decided to
investigate whether a Blimp-1 deficiency
in DCs might alter innate immune homeostasis in the intestine. We examined
Blimp-1 deletion in DC subsets and macrophages in the colon of BALB/c mice.

The majority of macrophages (CD103-F4/
80+CD64+) expressed moderate levels of
CD11c, and about 10% of macrophages
were CD11chi with a mean fluorescence
intensity equivalent to DCs (Figure 2A).
We isolated CD103+ DCs, CD11chi macrophages and CD11clow macrophages and
measured Blimp-1 expression. Although
there was no change in the level of Blimp-1
mRNA in total macrophages (CD11c+ and
CD11c–), CD11chi macrophages isolated
from Blimp-1cko mice showed significantly
reduced levels of Blimp-1 (Figure 2B). The
lack of reduction of Blimp-1 expression in
the whole macrophage population is likely
due to the relatively small proportion of
macrophages that are CD11chi. In contrast,
DCs (CD103+CD64–) showed a strong decrease in the level of Blimp-1 mRNA. Thus,
Blimp-1 deletion occurred in CD103+ DC
and CD11chi macrophages in these mice.
We also determined the expression of
Blimp-1 in CD103–CD11b+CX3CR1intCD64–
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DCs, a recently identified intestinal DC
subset (18). The level of Blimp-1 expression was low in this DC subset (~10-fold
less compared with CD103+CX3CR1–
DCs), and no significant difference was
observed between WT and Blimp-1cko
mice (Figure 2C).
We compared the inflammatory response to DSS-induced colitis in Blimp1cko and WT mice. WT mice showed a
significant but mild response to DSS and
fully recovered. Surprisingly, administration of the same concentration of DSS
to Blimp-1cko mice led to a faster onset
and more severe inflammatory response
with high mortality on both BALB/c
background (Figure 3A) and C57BL/6
background (data not shown). We decided to use Blimp-1cko on BALB/c for
further studies. Pathology of colon samples from both WT and Blimp-1cko mice
was compared on d 3 and 7 of DSS treatment. At the early time point (d 3), there
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Figure 2. Blimp-1 expression in DCs and macrophages. (A) Flow cytometry strategy of identifying colonic DC and macrophages. Graph
represents percentage of CD11chi cells in DCs and macrophages. Mean ± standard error of the mean (SE) are shown (n = 5). (B) DCs
and total CD64+F4/80+ macrophages (including CD11cint and CD11chi) (left graph) and CD11clow or CD11chi macrophages (right) were
sorted as depicted in (A), and the level of Blimp-1 was quantified by qPCR. Mean ± SE are shown (n = 3). (C) Blimp-1 expression was
measured by qPCR in CD103+ and CD103– colonic DCs from WT and Blimp-1cko mice. The graph presents the mean ± SE of three independent experiments.

was no clear difference observed in the
colon pathology (data not shown). In accordance with the greater weight loss
and mortality, colons harvested at d 7 of
DSS treatment of Blimp-1cko mice exhibited highly inflamed phenotypes (Figure 3B), increased weight with a shorter
length of colon and an increased histology score, compared with WT mice (Figure 3C). There were significant architectural changes including severe crypt
damage in the colons from Blimp-1cko
mice. In summary, these observations
demonstrate that there is an exacerbated
IBD pathology in mice with an absence
of Blimp-1 expression in both CD103+
DCs and a small population of CD11chi
macrophages.

DSS-Induced Mortality Is Not due to
Bacterial Spreading or a Different
Microbial Community
Appropriate induction of IgA and IgM
in mucosal lymphoid tissue is critical for
controlling bacterial spreading, and defects can lead to a high mortality in response to DSS administration, as
demonstrated in a MyD88ko mouse (27).
Therefore, we compared fecal immunoglobulin (Ig) levels and commensal
bacterial spreading to peripheral organs
in WT and Blimp-1cko mice. There was
no significant difference in the level of
IgG, IgM or IgA in fecal samples on d 7
of DSS administration (data not shown).
In addition to the normal immunoglobulin level, no bacteria were detected in

peripheral tissues, such as liver, mLNs
and blood of either strain (data not
shown). We also wanted to investigate
whether a difference in the commensal
bacterial community between WT and
Blimp-1cko mice might account for the
difference in colitis severity. It is known
that the bacterial community can affect
the development of colitis in this model
(8). Fecal pellets were collected from individual WT and Blimp-1cko mice, and
the composition of the bacterial community was analyzed by 16s RNA sequencing. There was no significant difference
between WT and Blimp-1cko mice. Both
groups of mice exhibit one dominant
genus, Clostridium (~80% of classified
bacteria), followed by others, Corprococ-
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Figure 3. Increased pathological phenotypes by DSS-induced colitis in Blimp-1cko mice. (A) Weight change and mortality was monitored
during DSS treatment and calculated based on d 0. DAI was determined at d 7 of DSS treatment. Mean ± SE are shown (n = 4). (B) Histology of colon from d 7 DSS-treated WT and Blimp-1cko mice. The distal colon was removed and fixed with 4% PFA. Hematoxylin and eosin
(H&E) staining was performed, and sections were imaged with a Xeiss camera at 5× and 10× magnification. Histology score was evaluated based on the level of damage in tissue and infiltration of mononuclear cells. (C) Colon length and weight were measured from
DSS-treated WT or Blimp-1cko mice. Each dot represents an individual mouse and the bar represents the mean ± SE (n = 5).

cus and Dehalobacterium (~5 and 3%
each). These data suggest that DSSinduced mortality in DCBlimp-1ko mice
is due to increased inflammation in the
intestine and irreversible tissue damage
rather than systemic bacteremia or a difference in the composition of commensal
bacteria.
Increased Expression of Inflammatory
Cytokines in Blimp-1cko Mice during
DSS Colitis
It is well known that an aberrant production of proinflammatory cytokines
plays a critical role in the pathogenesis of
IBD (28,29). There were very low levels
of expression of proinflammatory cytokines in entire colons and in isolated

myeloid cells (CD45+MHCII+CD11c+and
CD11b+) from both WT and Blimp-1cko
mice before DSS administration. However, DSS exposure significantly induced
proinflammatory cytokine expression, especially IL-1β, IL-6 and IL-23, in purified
colonic myeloid cells with a significantly
greater expression in myeloid cells from
Blimp-1cko mice (Figure 4A). We also observed increased expression of IL-6 and
IL-23 in myeloid cells from the small intestine of Blimp-1cko mice (data not
shown). The increased IL-23 expression
in myeloid cells suggested that the increased pathology might be due to an increase in TH17 cells in Blimp-1cko mice.
However, there was no difference in the
percent of TH17 cells in the colon be-
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tween WT and Blimp-1cko mice before or
after DSS treatment (Figure 4B), ruling
out the contribution of TH17-mediated
pathogenesis in this model. We also measured IL-10, a cytokine known to have an
important role in immune homeostasis in
the intestine, but there were no differences in expression between WT and
Blimp-1cko mice (Figure 4A).
To identify which myeloid cell population was responsible for the increased
proinflammatory cytokine expression,
CD103+ colonic DCs and macrophages
were isolated on d 3 of DSS treatment
and cytokine expression was measured.
The difference between WT and Blimp1cko mice was attributable to DCs rather
than macrophages (Figure 4C).
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Figure 4. Increased expression of proinflammatory cytokines in colonic DCs from Blimp-1cko mice. (A) Pro-/antiinflammatory cytokines
were measured in total myeloid cells in the colon. Each bar represents the mean ± SE (n = 4). (B) CD4+ T cells were purified from the
colon of d 0, 3, and 7 DSS-treated WT and Blimp-1cko mice and cultured in TH17 differentiation culture media for 4 d. The percentage of
IL-17A–positive cells was calculated from CD4+ T cells (mean ± SE) (n = 5). (C) DCs and Mϕ (macrophages) isolated from the colon with
or without DSS treatment in WT and Blimp-1cko mice. Cytokine expression was measured by qPCR (upper panels) and by ELISA (lower
panels). Each bar represents the mean ± SE (n = 4).

Alterations in Myeloid Cell Populations
in Blimp-1cko Mice during DSSInduced Colitis
An increased expression of proinflammatory cytokines can be due either to
their increased expression at the single
cell level or to the expansion of cytokineproducing DCs in Blimp-1cko mice. The
frequency of DCs and macrophages was
calculated as the number of DCs or macrophages normalized to the number of
total myeloid cells. No significant difference was observed in either the basal DC
or macrophage populations between WT
mice and Blimp-1cko mice (data not
shown). However, at d 3 of DSS exposure,
there was a decrease in DCs and an in-

crease in macrophages in the colon (Supplementary Figure S1A) and an increase
in macrophages in mLNs (Supplementary
Figure S1B) of Blimp-1cko mice compared
with WT mice. This difference was no
longer observed at d 7 of DSS treatment
(Supplementary Figure S1C). Thus, alteration in infiltrating cells was present only
at an early time point of DSS treatment
and was an intestine-restricted phenotype. The increased percentage of macrophages might be due to recruitment from
the periphery or proliferation of colonic
macrophages in response to inflammatory
factors presumably derived from DCs.
Together with an expansion of macrophages, we observed a strong infiltration

of polymorphonuclear neutrophils
(CD11bhiLy-6G+) in the colon of Blimp1cko mice compared with WT mice (Figure 5). This infiltration was significant on
d 3, consistent with increased inflammation at that early time point.
Increased Expression of MMPs by
Macrophages in the Colon
To understand the enhanced inflammation and severe mortality in Blimp-1cko
mice, we asked whether there might be
enhanced tissue destruction by the expanded macrophage population. Macrophages are known to be pathogenic in the
intestine through secretion of various tissue-damaging enzymes, including MMPs
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Figure 5. Increased influx of neutrophils
into the colon in DSS-treated Blimp-1cko
mice. Frequency of neutrophils was calculated within CD45+ MHCIIhi cells in mLN,
colon and small intestine (SI) from d 3 DSStreated WT or Blimp-1cko mice. Each dot
represents an individual mouse and the
bar represents the mean ± SE (n = 4).

(30,31). We measured MMPs in isolated
colonic macrophages during DSS administration. MMP-8, MMP-9 and MMP-12
mRNA was highly increased in colonic
macrophages from Blimp-1cko mice compared with WT mice on d 3 of DSS administration (Figure 6A). RNA for other
MMPs and protectins, such as MMP-2,
Ptsg2, Lta4h and Alox5ap, involved in
wound healing, did not differ between
control and Blimp-1cko mice (data not
shown). We also measured MMP mRNA
in DCs from the colon of mice given DSS;
the level of MMP expression in DCs was
minimal, and there was no detectable difference between Blimp-1cko and WT mice.
TNFα mRNA and protein was increased
and TGFβ mRNA decreased in colonic
macrophages from Blimp-1cko mice compared with WT mice (Figures 6B, C).
These data suggest that macrophages
from Blimp-1cko mice were skewed toward production of tissue-destructive
proteins during DSS-induced colitis.
CD103+ Colonic DCs Switch
Residential Macrophages into TissueDestructive Macrophages
To test whether Blimp-1ko DCs were responsible for the enhanced MMP expression in macrophages, we cultured macrophages with DCs in vitro. Macrophages
were generated from the BM of WT mice,

Figure 6. Increased expression of MMPs and proinflammatory cytokine in colonic macrophages from DSS-treated Blimp-1cko mice. At d 3 of DSS treatment, DCs and macrophages
were isolated from colons of WT or Blimp-1cko mice, and expression of MMPs (A) and cytokines (B) was measured by qPCR and ELISA (C). Means ± SE are shown (n = 6).

and DCs were prepared from the colon
of either WT or Blimp-1cko mice. To recapitulate the complex bacterial stimulation in the colon, we decided to use the
bacterial recognition motifs, LPS and
MDP, enabling activation of toll-like receptors (TLRs) and nucleotide-binding
oligomerization domain–containing protein 2 (NOD2) in DCs. These motifs were
chosen, since the importance of TLRs and
NOD2 in IBD is well described (32).
Colon-derived Blimp-1ko DCs preactivated
by MDP significantly enhanced MMP expression in macrophages compared with
MDP-preactivated WT DCs (Figure 7A).
In contrast, neither LPS-activated Blimp1ko DCs nor MDP-activated Blimp-1ko
BM-DCs enhanced MMP expression in
macrophages (Figure 7B). Direct activation of colonic macrophages with MDP
did not induce MMP expression in macrophages from WT or Blimp-1ko mice
(data not shown), suggesting specific
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molecules derived from colonic DCs are
required for induction of MMPs in
colonic macrophages. To determine
whether soluble factors secreted by
Blimp-1ko DCs were responsible for
MMP expression in macrophages, supernatants from MDP-stimulated Blimp-1ko
DCs were incubated with WT macrophages. MMP mRNA expression was
increased by exposure to secreted products of MDP-activated Blimp-1ko DCs
(Figure 7C). To confirm increased protein
expression by DC stimulation, MMP-12,
which was most highly expressed among
MMPs, was measured in culture supernatant. Figure 7D shows MMP-12 expression in the supernatant; only supernatant
from MDP-stimulated DCs induced
MMP-12 expression in macrophages.
Next, we compared cytokine expression
between WT and Blimp-1ko DCs stimulated with LPS or MDP to identify molecules responsible for induction of MMPs.
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Figure 7. Soluble factor derived from colonic DCs increased MMP expression in macrophages. Macrophages were cocultured with colonic
DCs (A) or BM-DCs (B) in vitro as described in Material and Methods. Supernatant was harvested and DCs and macrophages were separated by cell sorting to measure MMP by qPCR. The bar represents the mean ± SE (n = 4). (C) BM-macrophages were cultured without (gray
bar) or with conditioned medium (CM) prepared from (A), and then MMP expression was measured by qPCR. The bar represents the mean ±
SE (n = 4). (D) MMP-12 protein was measured by Western blotting. Supernatant were prepared from experiment (A), and anti–MMP-12 Western blotting was performed. For sample loading control, macrophages from the same experiments were lysed and actin level was measured.

IL-6 and IL-1β were significantly increased in MDP-activated (Figure 8A),
but not LPS-activated, colonic DCs (data
not shown). We therefore tested whether
IL-6 and IL-1β secreted from DCs were
responsible for increased MMP expression. Anti–IL-6 and –IL-1β neutralizing
antibodies were introduced during the
culture of macrophages. Blockade of both
cytokines significantly reduced MMP
mRNA expression compared with control antibody-treated macrophages, demonstrating that IL-6 and IL-1β are responsible for increased MMP in macrophages
(Figure 8B).
Blocking of IL-1β/IL-6 Reversed the
Colitis Phenotypes in Blimp-1cko Mice
To test whether IL-1β and/or IL-6
were responsible for the increased susceptibility to DSS-induced colitis in
Blimp-1cko mice, we administered neu-

Figure 8. Increased expression of IL-1β and IL-6 is responsible for enhanced MMP expression
in macrophages. (A) Cytokine levels were measured by MSD. Supernatants were prepared
from colonic DC from WT (open bar) or Blimp-1cko (closed bar) mice with or without stimulation with MDP. The bar represents the mean ± SE (n = 4). (B) Cytokines were blocked during macrophage activation with conditioned medium (CM) of MDP-preactivated DCs.
MMP expression was measured by qPCR. Each dot represents an individual mouse and
the bar represents the mean ± SE (n = 3).
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Figure 9. Blocking of IL-1β and IL-6 during the DSS treatment reduces colitis in Blimp-1cko mice. (A) Either control (ctl)-IgG or anti–IL-1β/6 neutralizing antibody was administered intraperitoneally (100 μg each antibody) on d 0, 3 and 5 of DSS treatment in WT and Blimp-1cko mice. Mortality (left) and weight loss (middle) was monitored. On the right panel, weight loss is shown at d 7 DSS treatment with ctl-IgG and either anti–IL-1β
or –IL-6. The bar represents the mean ± SE (n = 4). (B) WT and Blimp-1cko mice were treated with DSS for 3 d with either ctl-IgG or anti–IL-1β/6 intraperitoneally, and MMP expression was measured in colonic macrophages by qPCR. Means ± SE of three independent experiments are
shown. (C) Ctl-IgG, anti-TNFα neutralizing antibody (100 μg) or doxycycline (50 mg/kg) was administered intraperitoneally on d 0, 3 and 5 of
DSS treatment in WT and DCBlimp-1ko mice. DAI was calculated on d 7 of DSS treatment. Data are means ± SE (n = 3). n.s., Not significant.

tralizing antibodies to IL-1β/IL-6 during
DSS administration. Administration of
neutralizing antibodies to both IL-1β
and IL-6, but not control antibody, led to
improvements in mortality and weight
loss in Blimp-1cko mice (Figure 9A).
MMP-8, -9 and -12 mRNA expression
was downregulated in macrophages isolated from antibody-treated Blimp-1cko
mice (Figure 9B), demonstrating that
IL-1β and IL-6 contribute significantly to
the increased MMP mRNA expression in
macrophages. Blockade of IL-1β or IL-6
individually was not sufficient to improve clinical symptoms in Blimp-1cko
mice (Figure 9A, right panel) or to re-

duce MMP mRNA expression in macrophages (data not shown), suggesting that
either IL-1β or IL-6 can enhance colitis
susceptibility. Mounting evidence indicates the importance of TNFα in colitis
development (32). Because we observed
that TNFα secretion was increased in
macrophages from Blimp-1cko mice (Figure 6B), we administered anti-TNFα neutralizing antibody during DSS exposure.
TNFα blockade did not reduce colitis
severity in Blimp-1cko mice (Figure 9C),
suggesting that TNFα may not be the
major mechanism for tissue injury in this
model. To determine whether the increased MMP expression in macrophages
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was critical to the increased colitis phenotype, we administered doxycycline, a
pan-MMP inhibitor, during induction of
colitis. This treatment significantly improved the colitis phenotype (Figure 9C).
Blimp-1cko mice that were administered
doxycycline showed a low degree of inflammation in the colon with normal
stool, demonstrating that enhanced expression of MMPs in macrophages is a
mechanism of DSS colitis.
DISCUSSION
DSS-induced colitis is usually a selflimited condition in mice, characterized
by acute tissue inflammation in the
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colon, and initiated by the innate immune system. Our present study highlights a novel role for Blimp-1 in human
Mo-DCs and mouse CD103+ DCs in the
regulation of the inflammatory response
in the gut. Mo-DCs carrying the PRDM1
IBD risk allele exhibited a low level of
Blimp-1 and increased production of
proinflammatory cytokines on simulation with LPS. Blimp-1 deficiency in
CD103+ DCs rendered mice more susceptible to DSS-induced colitis with an increased mortality. Intestinal Blimp-1ko
DCs secrete increased levels of proinflammatory cytokines, IL-1β and IL-6,
presumably in response to commensal
bacteria, resulting in the enhanced activation of macrophages in the colon. Macrophages of Blimp-1cko mice are induced
during DSS colitis to express higher levels of MMPs with faster kinetics of expression. Inhibition of IL-1β and IL-6 or
MMPs can relieve colitis symptoms,
demonstrating that proinflammatory cytokines and MMPs from innate immune
cells are a major mechanism of pathology
in this mouse model of colitis.
In previous reports, Blimp-1 deficiency
was shown to function in different cell
types to cause inflammatory diseases.
Mice with a T-cell–specific Blimp-1 deletion develop intestinal inflammation (34),
probably mediated by a lack of functional T regulatory cells. More recently,
Blimp-1 in T cells has been shown to
limit Th17 differentiation, a T-cell subset
that contributes to intestinal inflammation (35). Mice with an epidermal-specific deletion of Blimp-1 develop chronic
skin inflammation with a higher level of
granulocyte colony-stimulating factor (GCSF) and enhanced myelopoiesis (36).
This study identifies a protective function of Blimp-1 in innate immune cells
and reveals how this protects against intestinal inflammation.
It is well accepted that in the steady
state, intestinal myeloid cells are tolerogenic and refractory to stimulation with
TLR agonists in contrast to myeloid cells
in the blood or in peripheral lymphoid
organs (37); therefore, uncontrolled cytokine production by myeloid cells con-

tributes to the pathogenesis of colitis
(38,39). Proinflammatory cytokines,
mostly secreted from DCs not macrophages, were highly expressed in colonic
myeloid cells from Blimp-1cko mice compared with WT mice after DSS exposure,
directly regulating the expression of
MMPS from macrophages and subsequently increasing tissue damage during
the development of colitis. This regulation appears to be tissue specific because
the increase in MMPs in macrophages is
induced by activated colonic DCs but not
BM-DCs.
MMPs are implicated in tissue destruction during inflammation (30).
There is a report of increased expression
of MMP-1 and MMP-2 in biopsies of patients with ulcerative colitis (40). Moreover, MMP expression correlates with regions of mucosal loss in IBD patients
(41). We did not observe significant
changes in MMP-1 or MMP-2 (data not
shown). Instead, there was an increased
expression of MMP-8, -9 and -12 in macrophages isolated from Blimp-1cko mice
compared with macrophages from WT
mice subjected to DSS colitis. Each MMP
has a specific set of target molecules.
MMP-8 and MMP-12 can bind to TNFα
and chemokines, respectively, and convert the inactive forms into active forms.
Therefore, increased expression of
MMPs can increase tissue damage directly by matrix degradation and indirectly by activation of proinflammatory
cytokines and chemokines, initiating an
inflammatory cascade in the mucosa. In
fact, the increased infiltration of neutrophils observed in the colon in Blimp1cko mice may reflect an increased secretion of neutrophil-attracting chemokines
from Blimp-1ko DCs and MMPs. Although we observed that an increased
secretion of chemokine (C-X-C motif) ligand 1 (CXCL1) in LPS stimulated Blimp1–deficient DCs in spleen, we did not
find the difference in colonic DCs before
and after DSS exposure (data not
shown). It is possible that the increased
MMP-12 cleaves the inactive form of
CXCL1 to convert it into an active form
of CXCL1 (42) or MMP-8/9 cleaves col-

lagen generating the proline–glycine–
proline peptide, which has chemotactic
effects on neutrophil (43). Although neutrophil migration is beneficial for killing
bacteria, it is presumed that persistent or
excessive neutrophil infiltration causes
tissue damage, and blocking of neutrophil infiltration can be beneficial in
DSS-mediated colitis (44,45).Therefore,
MMP-activated chemokines may be one
component of the pathogenic inflammatory cascade in Blimp-1cko mice.
While a number of studies have
demonstrated the direct activation of
adaptive immune cells by DCs, whether
DCs can directly regulate innate immune
cells has not been studied. The observation we made in this study (that CD103+
colonic DCs upregulate MMP expression
in macrophages) is therefore novel. This
regulatory activity is tissue specific and
agonist dependent. Compared to WT
DCs, Blimp-1–deficient DCs secrete increased levels of IL-1β and IL-6 after
stimulation with MDP, presumably
through activation of the MDP receptor
NOD2. We have shown that these cytokines are major contributors to MMP
expression in macrophages and to susceptibility to DSS, since administration of
neutralizing antibodies to IL-1β and IL-6
improved clinical symptoms of colitis
and diminished MMP induction. Currently, we do not know how Blimp-1 deficiency positively regulates MDPmediated NOD2 activation in colonic
DCs. NOD2 is a member of the NLR
(NOD-like receptor) family of proteins,
which regulate nuclear factor (NF)-κB activation and a subsequent inflammatory
cascade. A recent study showed that
Blimp-1 can negatively regulate
NLRP12/Monarch-1, another member of
the NLR family (46). We did not find any
report of Blimp-1 regulating NOD2 or
NOD2 downstream molecules, but perhaps NOD2 levels are increased in
Blimp-1ko DCs. We are currently investigating this possibility. It is also possible
that expression of IL-32 is increased in
the absence of Blimp-1, since IL-32 synergizes with NOD1/2 ligands to induce
IL-1β and IL-6 production (47).
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CONCLUSION
The results of the present study provide
several important insights into the function of DCs during intestinal inflammation. First, DC-restricted alterations can
increase susceptibility to intestinal inflammation. Blimp-1 deficiency in DCs induces enhanced production of IL-1β and
IL-6 on MDP stimulation; this phenotype
is present only in colonic DCs but not in
BM-DCs. Second, this enhanced cytokine
production directly regulates MMP expression in macrophages. Direct cross-talk
between DCs and macrophages has not
been previously reported or shown to
contribute to IBD pathogenesis. The hyperactivated phenotype of intestinal DCs
observed in our study is one of the consistently observed phenotypes of DCs from
IBD patients (48), suggesting that the
Blimp-1 colitis risk allele may exhibit decreased expression in intestinal DCs, a
new molecular pathway by lack of Blimp1 in colitis pathogenesis. We believe that
the current study suggests a novel mechanism for PRDM1-determined risk in initiation or disease progression in human
IBD and demonstrates that DCs not only
modify the function of cells within the
adaptive immune response but also modify function of innate immune cells.
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